Study to Investigate the Immune Response to Influenza Vaccine in Patients With Multiple Sclerosis on Teriflunomide
Clinical trial NCT01403376 · COMPLETED
Trial details
- NCT number
- NCT01403376
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2012-01-01
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.